7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0 Ma'ema'e >99.0% (HPLC) Aripiprazole Intermediate Factory
Hāʻawi ka mea hana i nā mea waena o Aripiprazole me ka maʻemaʻe kiʻekiʻe
Aripiprazole API CAS 129722-12-9
1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone CAS 129722-34-5
| Inoa Kimia | 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone |
| Nā huaʻōlelo like | 3,4-Dihydro-7-Hydroxy-2(1H)-Quinolinone;7-Hydroxy-3,4-Dihydrocarbostyril;7-Hydroxy-2-oxo-1,2,3,4-Tetrahydroquinoline;7-Hydroxycarbostyril;Aripiprazole haumia 5;Aripiprazole EP Impurity A |
| Helu CAS | 22246-18-0 |
| Helu CAT | RF-PI1981 |
| Kūlana Kūʻai | Ma ka waihona, ka mana hana 60MT/makahiki |
| ʻĀpana Molekala | C9H9NO2 |
| Kaumaha Molecular | 163.18 |
| Ka hikiwawe | Hiki ke hoʻoheheʻe ʻia i ka Methanol |
| ʻO ka mānoanoa | 1.282±0.060 g/cm3 |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Melemele ʻeleʻele a i ʻole ka pauda keʻokeʻo |
| Maʻemaʻe / Kaʻina Hanana | >99.5% (HPLC, Pākēneka ʻāpana) |
| Lae hehee | 229.0~235.0 ℃ |
| Nalo ma ka maloo | <0.50% |
| Waiwai (KF) | <0.50% |
| ʻO ka haumia hoʻokahi kiʻekiʻe | <0.30% |
| Huina paumaele | <0.50% |
| Infrared Spectrum | Kūlike i ka hoʻolālā |
| Kūlana hoʻāʻo | Kūlana ʻoihana |
| Hoʻohana | Kūwaena o Aripiprazole (CAS: 129722-12-9) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
Hiki ke hoʻohana ʻia ka Methyl 3-Bromobenzoate (CAS 618-89-3) ma ke ʻano he mua o Aripiprazole (CAS: 129722-12-9).ʻO Aripiprazole kahi ʻano hou o ka lipid soluble quinoline derivatives, ʻo kona ʻano hopena pharmacological ʻaʻole ia wale ka postsynaptic dopamine D 2 receptor antagonist, akā ʻo ka presynaptic dopamine D 2 receptor agonist, hiki iā ia ke hoʻoulu D 1, D 3, D 4 mea loaa;Loaʻa i ka Aripiprazole ka hopena ʻelua o ka hoʻāla ʻāpana a i ʻole ka mea hoʻokipa antagonistic ma 5-HT 1A receptor;loaʻa iā ia kahi hana antagonistic loa ma ka 5-HT 2A receptor.ʻOkoʻa kēia hiʻohiʻona mai ka hanauna mua, a me nā antipsychotics atypical e pili ana i ka lua o ka hanauna antipsychotic lāʻau, a no laila ua kapa ʻia ʻo dopamine system stabilizer a i ʻole ke kolu o ka hanauna antipsychotic.No ke kūʻai ʻia ʻana ma ka mākeke, hoʻohana nui ʻia ʻo Aripiprazole i ka schizophrenia clinical, ka mālama ʻana i nā maʻi maʻi a me nā maʻi psychiatric ʻē aʻe.E like me ka palapala, aripiprazole loaʻa nā hopena koʻikoʻi i ka schizophrenia maikaʻi a me nā hōʻailona maikaʻi ʻole a me ka hopohopo, ke kaumaha, ka hana cognitive, ʻoiai ʻoi aku ka palekana.AripiprazoleUa hōʻike pū ʻia e hiki i ka lāʻau lapaʻau ke mālama i nā maʻi noʻonoʻo ʻē aʻe, e like me nā maʻi ʻino manic episodes, senile dementia e pili ana me nā maʻi noʻonoʻo, nā maʻi hopohopo, nā maʻi kūlohelohe o nā keiki, ke kaumaha.
